Back
Xylem Vs. Harmony Biosciences Holdings Industry Stock Comparison
Buy
56
XYL
Xylem
Last Price:
144.29
Seasonality Move:
5.65%
Buy
63
HRMY
Harmony Biosciences Holdings
Last Price:
29.93
Seasonality Move:
3.2%
Buy
56
Xylem (XYL)
is a Buy
Is Xylem a Buy, Sell or Hold?
- The current Xylem [XYL] share price is $144.25. The Score for XYL is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
- XYL is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
63
Harmony Biosciences Holdings (HRMY)
is a Buy
Is Harmony Biosciences Holdings a Buy, Sell or Hold?
- The current Harmony Biosciences Holdings [HRMY] share price is $29.95. The Score for HRMY is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
- HRMY is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
XYL Stock Price Chart
HRMY Stock Price Chart
What is Harmony Biosciences Holdings's stock price today?
-
The Harmony Biosciences Holdings share price today is $29.95
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HRMY is experiencing buying pressure, which is a positive indicator for future bullish movement.
XYL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.66 | Buy |
| Relative Strength Index (14 RSI): | 67.86 | Buy |
| Chaikin Money Flow: | 278284 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (132.87 - 144.33) | Buy |
| Bollinger Bands (100): | (116.8 - 136.02) | Buy |
HRMY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.24 | Sell |
| Relative Strength Index (14 RSI): | 48.53 | Sell |
| Chaikin Money Flow: | 163252 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (29.18 - 30.96) | Sell |
| Bollinger Bands (100): | (29.93 - 32.79) | Sell |
XYL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 144.34 | Sell |
| 20-day SMA: | 140.58 | Buy |
| 50-day SMA: | 133.39 | Buy |
| 200-day SMA: | 112.75 | Buy |
| 8-day EMA: | 143.89 | Buy |
| 20-day EMA: | 140.73 | Buy |
| 50-day EMA: | 134.63 | Buy |
| 200-day EMA: | 119.14 | Buy |
HRMY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 29.61 | Buy |
| 20-day SMA: | 30.3 | Sell |
| 50-day SMA: | 30.74 | Sell |
| 200-day SMA: | 30.89 | Sell |
| 8-day EMA: | 29.81 | Buy |
| 20-day EMA: | 30.03 | Sell |
| 50-day EMA: | 30.5 | Sell |
| 200-day EMA: | 32.07 | Sell |
Xylem Earnings Growth & XYL Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.23 per share, an increase next quarter of $0.07 per share, an increase this year of $0.48 per share, and an increase next year of $0.51 per share.
Harmony Biosciences Holdings Earnings Growth & HRMY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.15 per share, an increase next quarter of $0.11 per share, an increase this year of $0.64 per share, and an increase next year of $1.54 per share.
Xylem Technical Analysis
| May 13 | May 14 | May 15 | May 16 | May 17 | May 20 | May 21 | May 22 | May 23 | May 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 13 | 14 | 15 | 16 | 17 | 20 | 21 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Harmony Biosciences Holdings Technical Analysis
| May 13 | May 14 | May 15 | May 16 | May 17 | May 20 | May 21 | May 22 | May 23 | May 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 13 | 14 | 15 | 16 | 17 | 20 | 21 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||